Veru, Inc. (VERU)
2.39
+0.05
(+2.14%)
USD |
NASDAQ |
Dec 26, 16:00
2.39
0.00 (0.00%)
After-Hours: 19:09
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 35.03M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -62.76% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | 1.911 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.17 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 99.07% |
Profile
| Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL. |
| URL | http://www.verupharma.com |
| Investor Relations URL | https://ir.verupharma.com/ |
| HQ State/Province | Florida |
| Sector | Consumer Staples |
| Industry | Personal Care Products |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Aug. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 28, 2014 |
Ratings
Profile
| Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL. |
| URL | http://www.verupharma.com |
| Investor Relations URL | https://ir.verupharma.com/ |
| HQ State/Province | Florida |
| Sector | Consumer Staples |
| Industry | Personal Care Products |
| Next Earnings Release | Feb. 12, 2026 (est.) |
| Last Earnings Release | Aug. 12, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 28, 2014 |